Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG39021

DNAAF2 Knockout HAP1 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone Marrow

  • Disease:

    Chronic myeloid leukemia

The DNAAF2 Knockout HAP1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population in the near-haploid HAP1 cell line, targeting the DNAAF2 gene. DNAAF2 functions as a cytoplasmic co-chaperone essential for assembly of outer dynein arm complexes, interacting with the R2TP?CHSP90 network and DNAAF1 to stabilize dynein heavy chains such as DNAH5 and DNAH11 prior to ciliary transport. Disruption of DNAAF2 leads to immotile cilia, defective mucociliary clearance, and aberrant left-right axis specification, recapitulating primary ciliary dyskinesia phenotypes. Applications include modeling ciliopathies, studying DNAAF2 interactors (SPAG1, ZMYND10), and screening for compounds that restore ciliary beat frequency.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HAP1

    Sex of Donor

    Male

    Age

    40 years

    Derived From Site

    Bone marrow

    Gene Name

    DNAAF2

    Gene Identifier

    NCBI Gene ID 55172

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    IMDM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The DNAAF2 Knockout HAP1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population targeting the DNAAF2 gene. This heterogeneous pool of HAP1 cells harbors various gene disruptions, generating a loss-of-function model of the cytoplasmic preassembly factor essential for outer dynein arm formation. The polyclonal format captures a spectrum of editing outcomes, avoiding clone-specific artifacts and enabling robust functional screening.

The parental HAP1 cell line is a near-haploid human model derived from the CML KBM-7 line, carrying the BCR-ABL1 fusion oncogene and disomy for chromosome 8. This karyotype simplifies genetic studies, and the cells?? ability to form primary cilia upon serum starvation renders them suitable for ciliogenesis research despite their hematopoietic origin.

DNAAF2 acts as a cytoplasmic co-chaperone, collaborating with the R2TP?CHSP90 network and DNAAF1 (LRRC50) to promote assembly of outer dynein arm complexes. It facilitates folding and stabilization of heavy chains (DNAH5, DNAH11), intermediate chains (DNAI1, DNAI2), and light chains before ciliary transport. Transcription of DNAAF2 is regulated by ciliogenic factors including FOXJ1, RFX3, and Multicilin, with influence from Notch signaling. Loss of DNAAF2 disrupts dynein arm preassembly, leading to immotile cilia, impaired mucociliary clearance, and randomized left-right asymmetry, as seen in primary ciliary dyskinesia and Kartagener syndrome.

In the near-haploid HAP1 background, DNAAF2 knockout eliminates functional redundancy, providing clear loss-of-function phenotypes. The BCR-ABL1 signaling context may offer opportunities to explore intersections between oncogenic pathways and ciliary biology. Inducible ciliogenesis by serum starvation allows direct evaluation of ciliary motility, axonemal ultrastructure, and protein localization using high-speed microscopy and electron microscopy.

This model supports diverse applications including PCD modeling, genetic modifier screening, validation of DNAAF2-interacting partners (e.g., DNAAF1, SPAG1, ZMYND10), and high-throughput screening for agents that restore ciliary motility. Recommended analytical readouts include Sanger sequencing, western blotting, RT-qPCR, immunofluorescence for ciliary markers, co-immunoprecipitation of assembly complexes, and ciliary beat frequency assays. For additional information, contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)